Advertisement

OneOncology Announces Lee Schwartzberg, MD, FACP, as Chief Medical Officer


Advertisement
Get Permission

Lee Schwartzberg, MD, FACP

Lee Schwartzberg, MD, FACP

OneOncology, the national partnership of community oncologists, has announced that Lee Schwartzberg, MD, FACP, has been named Chief Medical Officer. The Chief Medical Officer position provides a link between OneOncology and its physician partners, demonstrating the shared, foundational commitment to a physician-driven, data-driven, technology-powered, patient-centric organization.

OneOncology has a physician-centric approach to decision-making to ensure that clinical best practices are successfully implemented throughout the organization. The company has established a physician governance board comprising oncologists from each practice to direct the Chief Medical Officer and -OneOncology’s executive team on clinical initiatives. Together, the office of the Chief Medical Officer and the physician governance board advance clinical and technologic infrastructures, support the transition to value-based care, and establish the roadmap for analytics to support quality metrics and outcomes.

Professional Experience and Research Interests

In addition to his Chief Medical Officer role, Dr. Schwartzberg is a member of the OneOncology Board of Directors, Medical Director of West Cancer Center and Research Institute, and Professor of Medicine at The University of Tennessee Health Science Center. He will maintain his medical position with West Cancer Center and continue to see patients as a breast medical oncologist.

Dr. Schwartzberg is also the founding Editor-in-Chief of the journal Community Oncology and currently serves as Editor-in-Chief of Practice Update Oncology. He served on the Board of Directors for the National Comprehensive Cancer Network® (NCCN®) and participated actively as an NCCN Guideline Panel member for the NCCN Breast, Antiemesis, and Myeloid Growth Factor Panels for 7 years. In addition, he founded and served as Executive Director of the Ambulatory Care Outcomes Research Network. His research interests include new therapeutic approaches to breast cancer, targeted therapy, and supportive care. 


Advertisement

Advertisement



;
Advertisement